STOCK TITAN

Outset Medical, Inc. - $OM STOCK NEWS

Welcome to our dedicated page for Outset Medical news (Ticker: $OM), a resource for investors and traders seeking the latest updates and insights on Outset Medical stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Outset Medical's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Outset Medical's position in the market.

Rhea-AI Summary
Outset Medical, Inc. (OM) reported unaudited revenue for Q4 and fiscal year ended December 31, 2023, with revenue totaling $30.5 million in Q4 and $130 million for the year, a 13% increase from 2022. The period-end installed base increased 34% year-over-year to approximately 5,350 Tablo Hemodialysis Systems, with consumable revenue growing nearly 50% year-over-year. Outset's cash position is now approximately $270 million. 2024 revenue is expected to be between $145 million to $153 million, growing 12% to 18% over unaudited revenue for 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.41%
Tags
none
-
Rhea-AI Summary
Outset Medical, Inc. (OM) to present at J.P. Morgan Healthcare conference on January 8, 2024
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.24%
Tags
conferences
-
Rhea-AI Summary
Outset Medical, Inc. (OM) to participate in virtual panel discussion at BofA Securities Home Care Conference
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.96%
Tags
conferences
Rhea-AI Summary
Outset Medical, Inc. (OM) announces participation in Stifel 2023 Healthcare Conference and Jefferies London Healthcare Conference. Management to engage in fireside chats at the events. Live and archived webcasts available on the Outset website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.66%
Tags
conferences
-
Rhea-AI Summary
Outset Medical, Inc. (OM) Reiterates 2023 Revenue Guidance of $130 Million, Reports Q3 2023 Revenue of $30.4 Million, and Gross Margin of 23.6%. Net Loss Was ($46.2) Million, Non-GAAP Net Loss of ($35.3) Million. Operating Expenses Were $52.6 Million. Outset reiterated its 2023 revenue guidance of approximately $130 million and its previous gross margin guidance for the year to be in the low-20% range, exiting the fourth quarter in the mid-20% range.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-14.39%
Tags
-
Rhea-AI Summary
Outset Medical, Inc. announces significant data findings on the use of Tablo Hemodialysis System, including increased racial diversity among users, enhanced patient outcomes in the Medicare fee-for-service population, and decreased hospital transfers in rural Alaskan communities. The findings will be presented at the American Society of Nephrology's Kidney Week 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.21%
Tags
none
Rhea-AI Summary
Outset Medical, Inc. (Nasdaq: OM) will release its financial results for Q3 2023 on November 7, 2023, after the close of trading. Leslie Trigg, Chair and CEO, and Nabeel Ahmed, CFO, will host a conference call at 2:00 pm Pacific Time to discuss the results. Interested participants can register online to listen to the call.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
15.31%
Tags
conferences earnings
-
Rhea-AI Summary
Berman Tabacco investigates potential securities law violations by Outset Medical Inc.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-49.93%
Tags
none
-
Rhea-AI Summary
Outset Medical, Inc. announces preliminary financial results for Q3 2023 and updated financial guidance for 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-49.93%
Tags
Rhea-AI Summary
Outset Medical to participate in fireside chat at Morgan Stanley Healthcare Conference
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.49%
Tags
conferences
Outset Medical, Inc.

Nasdaq:OM

OM Rankings

OM Stock Data

195.95M
49.62M
3.97%
104.48%
16.55%
Electromedical and Electrotherapeutic Apparatus Manufacturing
Manufacturing
Link
United States of America
SAN JOSE

About OM

outset is a pioneering medical technology company that always puts the patient before the machine. our human-centered model is designed to dramatically improve not only the care experience – for patients, families, providers and physicians alike – but also cost-efficiencies for providers. and to achieve this goal, we brought together the most dedicated, creative minds from dialysis with the most dedicated, creative minds from other healthcare fields, in the belief that cross-fertilization – along with hard work – is the surest path to invention. because we believe a dialysis machine should be as easy to use as an everyday consumer product, tablo was designed with simplicity in mind. one example is tablo’s touchscreen display, which offers step-by-step pictures and conversational instructions that make it hard to mess up no matter how new a patient, or caregiver, may be to dialysis. and with simplicity comes speed. we’ve set out to give people their time back. tablo dramatically reduces